Abstract
An outbreak of SARS-CoV2 infection in a Barcelona prison was studied after seven cases appeared in nine days. One hundred and eighty-four people (148 inmates and 36 prison staff) were evaluated by rt-PCR. Thirty-nine (24.1%) were positive: 33 inmates and six staff members. The inmates were isolated in prison module 4, which was converted into an emergency COVID unit. Two people (one inmate and one health worker) were admitted to hospital for clinical deterioration. There were no deaths. Outbreaks pose a huge risk, must be detected early, are difficult to manage, and require optimal coordination between health and prison authorities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There are no funders to report for this submission
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Does your study require ethical approval? No
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Andrés Marco (amarco{at}gencat.cat); Carlos Gallego (27929cgc{at}comb.cat); Violeta Pérez-Cáceres (vperez.bnm.ics{at}gencat.cat); Rafael Alonso Guerrero (rguerrero{at}gencat.cat); Montserrat Sánchez-Roig (msanchezr{at}gencat.cat), M Rosa Sala Farré (mrosa.salaf{at}gencat.cat); Juan Fernández-Nager (joanfernandez{at}gencat.cat) and Elisabet Turu (eturu{at}gencat.cat).
Contact Information: Andrés Marco, Infectious Diseases, Prison Health Program, Catalan Institute of Health, Gran Via de les Corts Catalanes, 587-589, 08004 Barcelona, Spain, Teléfono: 00349348241 00; Fax 0034934824525, amarco{at}gencat.cat
Data Availability
I declare the availability of all the data referred to in the manuscript
